These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 6150493
1. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate. Carney MW. Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493 [Abstract] [Full Text] [Related]
2. Long-term treatment of chronic schizophrenics with clopenthixol decanoate. Borsetti G, Rocco P, Spilimbergo PG, Giavedoni A, Frangiamone L, Beccaceci A, Judice A, Cisternino M, Volterra V. Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492 [Abstract] [Full Text] [Related]
4. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients. Walker CA. Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287 [Abstract] [Full Text] [Related]
5. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients. Viswanathan R, Rajhkowa S. Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227 [Abstract] [Full Text] [Related]
11. Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate. Szukalski B, Lipska B, Welbel L, Nurowska K. Psychopharmacology (Berl); 1986 Jun; 89(4):428-31. PubMed ID: 2875481 [Abstract] [Full Text] [Related]
12. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate. Dencker SJ, Lepp M, Malm U. Acta Psychiatr Scand Suppl; 1980 Jun; 279():10-28. PubMed ID: 6931470 [Abstract] [Full Text] [Related]
13. [Maintenance therapy using clopenthixol decanoate in schizophrenic patients]. Kabes J, Balon R, Papezová H. Cesk Psychiatr; 1986 Aug; 82(3-4):189-94. PubMed ID: 3769007 [No Abstract] [Full Text] [Related]
15. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients. Izmeth MG, Khan SY, Kumarajeewa DI, Shivanathan S, Veall RM, Wiley YV. Pharmatherapeutica; 1988 Aug; 5(4):217-27. PubMed ID: 2902642 [Abstract] [Full Text] [Related]
16. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, Mølbjerg C. Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680 [Abstract] [Full Text] [Related]
17. Open clinical study of cis(Z)-clopenthixol. Sechter D, Caillard V, Cuche H, Deniker P. Acta Psychiatr Scand Suppl; 1981 Jul; 294():20-4. PubMed ID: 6951393 [Abstract] [Full Text] [Related]
18. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients. Heikkilä L, Karsten D, Valli K. Acta Psychiatr Scand Suppl; 1981 Jul; 294():25-9. PubMed ID: 7041516 [Abstract] [Full Text] [Related]
19. The decanoates of flupenthixol and clopenthixol in the treatment of chronic schizophrenic in-patients. Implications for community psychiatry. Martyns-Yellowe IS. West Afr J Med; 1993 Jul; 12(2):110-3. PubMed ID: 8104468 [Abstract] [Full Text] [Related]